ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells

References

• Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31(1):100–110. doi:10.1093/carcin/bgp263
   PubMed Web of Science ®Google Scholar
• Oh JH, Jun DW. The latest global burden of liver cancer: a past and present threat. Clin Mol Hepatol. 2023;29(2):355–357. doi:10.3350/cmh.2023.0070
   PubMed Web of Science ®Google Scholar
• Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–1606. doi:10.1016/j.jhep.2022.08.021
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Ca a Cancer J Clinicians. 2023;73(1):17–48. doi:10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584–590. doi:10.1097/CM9.0000000000002108
   PubMed Web of Science ®Google Scholar
• Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(15):4115–4127. doi:10.3748/wjg.v20.i15.4115
   PubMed Web of Science ®Google Scholar
• Psilopatis I, Damaskos C, Garmpi A, et al. FDA-approved monoclonal antibodies for unresectable hepatocellular carcinoma: what do we know so far? Int J Mol Sci. 2023;24(3):2685. doi:10.3390/ijms24032685
   PubMed Web of Science ®Google Scholar
• Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3(1):7. doi:10.1038/s41392-017-0004-3
   PubMed Web of Science ®Google Scholar
• Narvekar M, Xue HY, Eoh JY, Wong HL. Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions. AAPS Pharm Sci Tech. 2014;15(4):822–833. doi:10.1208/s12249-014-0107-x
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71. doi:10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Prasad M, Lambe UP, Brar B, et al. Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed. Pharmacother. 2018;97:1521–1537. doi:10.1016/j.biopha.2017.11.026
   PubMed Web of Science ®Google Scholar
• Yadav P, Bandyopadhyay A, Chakraborty A, Sarkar K. Enhancement of anticancer activity and drug delivery of chitosan-curcumin nanoparticle via molecular docking and simulation analysis. Carbohydr Polym. 2018;182:188–198. doi:10.1016/j.carbpol.2017.10.102
   PubMed Web of Science ®Google Scholar
• Witika BA, Makoni PA, Matafwali SK, et al. Biocompatibility of biomaterials for nanoencapsulation: current approaches. Nanomaterials. 2020;10(9):1649. doi:10.3390/nano10091649
   Web of Science ®Google Scholar
• Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017;9(4):53. doi:10.3390/pharmaceutics9040053
   PubMed Web of Science ®Google Scholar
• Yanat M, Schroën K. Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging. React Funct Polym. 2021;161:104849. doi:10.1016/j.reactfunctpolym.2021.104849
   Web of Science ®Google Scholar
• Sachdeva B, Sachdeva P, Negi A, et al. Chitosan nanoparticles-based cancer drug delivery: application and challenges. Mar Drugs. 2023;21(4):211. doi:10.3390/md21040211
   PubMed Web of Science ®Google Scholar
• Loutfy SA, El-Din HMA, Elberry MH, Allam NG, Hasanin M, Abdellah AM. Synthesis, characterization and cytotoxic evaluation of chitosan nanoparticles: in vitro liver cancer model. Adv Nat Sci. 2016;7(3):035008.
   Google Scholar
• Quagliariello V, Masarone M, Armenia E, et al. Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells. Oncol Rep. 2019;41(3):1476–1486. doi:10.3892/or.2018.6932
   PubMed Web of Science ®Google Scholar
• Pan Q, Lv Y, Williams GR, et al. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. Carbohydr Polym. 2016;151:812–820. doi:10.1016/j.carbpol.2016.06.024
   PubMed Web of Science ®Google Scholar
• Qi X, Rui Y, Fan Y, Chen H, Ma N, Wu Z. Galactosylated chitosan-grafted multiwall carbon nanotubes for pH-dependent sustained release and hepatic tumor-targeted delivery of doxorubicin in vivo. Colloids Surf B. 2015;133:314–322. doi:10.1016/j.colsurfb.2015.06.003
   PubMed Web of Science ®Google Scholar
• Chavda VP, Balar PC, Patel SB. Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics. 2023;7(2):128. doi:10.7150/ntno.80120
   PubMedGoogle Scholar
• B-l Y, Zheng R, Ruan X-J, Zheng Z-H, Cai H-J. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway. Biochem. Biophys. Res. Commun. 2018;495(1):414–420. doi:10.1016/j.bbrc.2017.10.156
   PubMed Web of Science ®Google Scholar
• Mintz KJ, Leblanc RM. The use of nanotechnology to combat liver cancer: progress and perspectives. Bioch et Bioph Acta. 2021;1876(2):188621. doi:10.1016/j.bbcan.2021.188621
   Web of Science ®Google Scholar
• Bonferoni MC, Gavini E, Rassu G, Maestri M, Giunchedi P. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials Basel. 2020;10(5):870. doi:10.3390/nano10050870
   Web of Science ®Google Scholar
• Guadarrama-Escobar OR, Serrano-Castañeda P, Anguiano-Almazán E, et al. Chitosan nanoparticles as oral drug carriers. Int J Mol Sci. 2023;24(5):4289. doi:10.3390/ijms24054289
   PubMed Web of Science ®Google Scholar
• Fathi M, Zangabad PS, Majidi S, Barar J, Erfan-Niya H, Omidi Y. Stimuli-responsive chitosan-based nanocarriers for cancer therapy. Bioimpacts. 2017;7(4):269. doi:10.15171/bi.2017.32
   PubMed Web of Science ®Google Scholar
• Ganeshpurkar A, Saluja AK. The pharmacological potential of rutin. Saudi Pharmac J. 2017;25(2):149–164. doi:10.1016/j.jsps.2016.04.025
   PubMed Web of Science ®Google Scholar
• Vachirapatama N, Chamna B. Separation and determination of rutin in apples by high performance liquid chromatography. Sci Technol Asia. 2012;2012:27–33.
   Google Scholar
• Vachirapatama N, Chamnankid B, Kachonpadungkitti Y. Determination of rutin in buckwheat tea and Fagopyrum tataricum seeds by high performance liquid chromatography and capillary electrophoresis. Journal of Food and Drug Analysis. 2011;19(4):18.
   Web of Science ®Google Scholar
• Pandey P, Khan F, Qari HA, Oves M. Rutin (Bioflavonoid) as cell signaling pathway modulator: prospects in treatment and chemoprevention. Pharmaceuticals. 2021;14(11):1069. doi:10.3390/ph14111069
   Web of Science ®Google Scholar
• Qanash H, Al-Rajhi AMH, Almashjary MN, Basabrain AA, Hazzazi MS, Abdelghany TM. Inhibitory potential of rutin and rutin nano-crystals against Helicobacter pylori, colon cancer, hemolysis and Butyrylcholinesterase in vitro and in silico. Appl Biol Chem. 2023;66(1):79. doi:10.1186/s13765-023-00832-z
   Web of Science ®Google Scholar
• Semwal R, Joshi SK, Semwal RB, Semwal DK. Health benefits and limitations of rutin - A natural flavonoid with high nutraceutical value. Phytochem Lett. 2021;46:119–128. doi:10.1016/j.phytol.2021.10.006
   Web of Science ®Google Scholar
• Nouri Z, Fakhri S, Nouri K, Wallace CE, Farzaei MH, Bishayee A. Targeting multiple signaling pathways in cancer: the rutin therapeutic approach. Cancers. 2020;12(8):2276. doi:10.3390/cancers12082276
   PubMed Web of Science ®Google Scholar
• Aydin RST, Pulat M. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J Nanomater. 2012;2012:42–42.
   Web of Science ®Google Scholar
• Naeem A, Yu C, Zang Z, Zhu W, Deng X, Guan Y. Synthesis and evaluation of rutin-hydroxypropyl β-cyclodextrin inclusion complexes embedded in xanthan gum-based (HPMC-g-AMPS) hydrogels for oral controlled drug delivery. Antioxidants. 2023;12(3). doi:10.3390/antiox12030552
   Web of Science ®Google Scholar
• Luo S, Fu Y, Ye J, Liu C. Encapsulation of rutin in protein nanoparticles by pH‐driven method: impact of rutin solubility and mechanisms. J Sci Food Agric. 2024;104(3):1804–1812. doi:10.1002/jsfa.13068
   PubMedGoogle Scholar
• Satari A, Ghasemi S, Habtemariam S, Asgharian S, Lorigooini Z. Rutin: a flavonoid as an effective sensitizer for anticancer therapy; insights into multifaceted mechanisms and applicability for combination therapy. Evid Based Complement Alternat Med. 2021;2021. doi:10.1155/2021/9913179
   PubMed Web of Science ®Google Scholar
• Han Y, Wang L, Jiang W, et al. An enhanced stability nanoparticle preparation by corn protein hydrolysate‐carboxymethyl chitosan Maillard conjugates loaded with rutin. Journal of Food Science. 2019;84(7):1829–1835. doi:10.1111/1750-3841.14616
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Naqvi AA, et al. Quantification of rutin in rat’s brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles. EXCLI J. 2016;15:518. doi:10.17179/excli2016-361
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Dwarampudi LP, Kadiyala M, et al. Formulation and characterization of chitosan encapsulated phytoconstituents of curcumin and rutin nanoparticles. Int J Biol Macromol. 2017;104:1807–1812. doi:10.1016/j.ijbiomac.2017.06.112
   PubMed Web of Science ®Google Scholar
• Chang C, Zhang L, Miao Y, Fang B, Yang Z. Anticancer and apoptotic-inducing effects of rutin-chitosan nanoconjugates in triple negative breast cancer cells. Journal of Cluster Science. 2021;32(2):331–340. doi:10.1007/s10876-020-01792-w
   Web of Science ®Google Scholar
• Devi KR, Paulraj SJ, Shah Y, Kumar SR, Kejamurthy P. Chitosan-tripolyphosphate nanoparticles encapsulated rutin targeting bacterial growth inhibition and its cytotoxicity on PANC-1 pancreatic adenocarcinoma cell. J Appl Pharm Sci. 2023;13(4):141–148.
   Google Scholar
• Ahmad N, Ahmad R, Naqvi AA, et al. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia. Int J Biol Macromol. 2016;91:640–655. doi:10.1016/j.ijbiomac.2016.06.001
   PubMed Web of Science ®Google Scholar
• Cosco D, Failla P, Costa N, et al. Rutin-loaded chitosan microspheres: characterization and evaluation of the anti-inflammatory activity. Carbohydr Polym. 2016;152:583–591. doi:10.1016/j.carbpol.2016.06.039
   PubMed Web of Science ®Google Scholar
• Nandana CN, Christeena M, Bharathi D. Synthesis and characterization of chitosan/silver nanocomposite using rutin for antibacterial, antioxidant and photocatalytic applications. Journal of Cluster Science. 2021;33:1–11.
   Web of Science ®Google Scholar
• Sionkowska A, Lewandowska K, Kurzawa M. Chitosan-based films containing rutin for potential cosmetic applications. Polymers. 2023;15(15):3224. doi:10.3390/polym15153224
   PubMed Web of Science ®Google Scholar
• Tran NQ, Joung YK, Lih E, Park KD. In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules. 2011;12(8):2872–2880. doi:10.1021/bm200326g
   PubMed Web of Science ®Google Scholar
• Abhishek Singh T, Sadhukhan P, Ghosh N, et al. Targeted delivery of rutin into breast cancer cells via using phenylboronic acid functionalized MgO nanoparticles. Materials Science and Engineering: B. 2023;296:116623. doi:10.1016/j.mseb.2023.116623
   Web of Science ®Google Scholar
• Li Y, Guo J, Gong X, et al. Inhibitory effects of platinum nanoparticles coated with polyethylene glycol and conjugated with Rutin on the MCF-7 breast cancer cell line. Arabian J Chem. 2024;17(3):105567. doi:10.1016/j.arabjc.2023.105567
   Web of Science ®Google Scholar
• Sathiyaseelan A, Saravanakumar K, Manivasagan P, Jeong MS, Jang E-S, Wang M-H. Folic acid conjugated chitosan encapsulated palladium nanoclusters for NIR triggered photothermal breast cancer treatment. Carbohydr Polym. 2022;280:119021. doi:10.1016/j.carbpol.2021.119021
   PubMed Web of Science ®Google Scholar
• Paudel KR, Wadhwa R, Tew XN, et al. Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Life Sci. 2021;276:119436. doi:10.1016/j.lfs.2021.119436
   PubMed Web of Science ®Google Scholar
• Hoai TT, Yen PT, Dao TTB, et al. Evaluation of the cytotoxic effect of rutin prenanoemulsion in lung and colon cancer cell lines. J Nanomater. 2020;2020:1–11. doi:10.1155/2020/8867669
   Web of Science ®Google Scholar
• Caparica R, Júlio A, Araújo MEM, et al. Anticancer Activity of Rutin and Its Combination with Ionic Liquids on Renal Cells. Biomolecules. 2020;10(2):233. doi:10.3390/biom10020233
   PubMed Web of Science ®Google Scholar
• Memar MY, Dalir Abdolahinia E, Yekani M, Kouhsoltani M, Sharifi S, Maleki Dizaj S. Preparation of rutin-loaded mesoporous silica nanoparticles and evaluation of its physicochemical, anticancer, and antibacterial properties. Mol Bio Rep. 2023;50(1):203–213. doi:10.1007/s11033-022-07953-6
   PubMed Web of Science ®Google Scholar
• Al‐Ekaid NM, Al‐Samydai A, Al‐deeb I, Nsairat H, Khleifat K, Alshaer W. Preparation, characterization, and anticancer activity of pegylated nano liposomal loaded with rutin against human carcinoma cells (HT‐29). Chem Biodivers. 2023;20(11):e202301167. doi:10.1002/cbdv.202301167
   PubMed Web of Science ®Google Scholar
• Kunjiappan S, Panneerselvam T, Somasundaram B, et al. Design, in silico modeling, biodistribution study of rutin and quercetin loaded stable human hair keratin nanoparticles intended for anticancer drug delivery. Biomed Phys Eng Express. 2018;4(2):025019. doi:10.1088/2057-1976/aaa1cf
   Google Scholar
• Pandian SRK, Pavadai P, Vellaisamy S, et al. Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor. Naunyn-Schmiedeberg’s Arch Pharmacol. 2021;394:735–749. doi:10.1007/s00210-020-02015-9
   Google Scholar
• AbouSamra MM, Afifi SM, Galal AF, Kamel R. Rutin-loaded Phyto-Sterosomes as a potential approach for the treatment of hepatocellular carcinoma: in-vitro and in-vivo studies. J Drug Delivery Sci Technol. 2023;79:104015. doi:10.1016/j.jddst.2022.104015
   Web of Science ®Google Scholar
• Pandey P, Rahman M, Bhatt PC, et al. Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin. Nanomedicine. 2018;13(8):849–870. doi:10.2217/nnm-2017-0306
   PubMed Web of Science ®Google Scholar
• Abbasi M, Gholizadeh R, Kasaee SR, et al. An intriguing approach toward antibacterial activity of green synthesized Rutin-templated mesoporous silica nanoparticles decorated with nanosilver. Sci Rep. 2023;13(1):5987. doi:10.1038/s41598-023-33095-1
   PubMed Web of Science ®Google Scholar
• Memar MY, Yekani M, Sharifi S, Dizaj SM. Antibacterial and biofilm inhibitory effects of rutin nanocrystals. Biointerface Res Appl Chem. 2022;13:132.
   Web of Science ®Google Scholar
• Abhishek Singh T, Kundu M, Chatterjee S, et al. Synthesis of Rutin loaded nanomagnesia as a smart nanoformulation with significant antibacterial and antioxidant properties. Inorg Chem Commun. 2022;140:109492. doi:10.1016/j.inoche.2022.109492
   Web of Science ®Google Scholar
• Kamel R, Mostafa DM. Rutin nanostructured lipid cosmeceutical preparation with sun protective potential. J Photochem Photobiol B Biol. 2015;153:59–66. doi:10.1016/j.jphotobiol.2015.09.002
   PubMed Web of Science ®Google Scholar
• Mohamed KM, Abdelfattah MS, El-khadragy M, et al. Rutin-loaded selenium nanoparticles modulated the redox status, inflammatory, and apoptotic pathways associated with pentylenetetrazole-induced epilepsy in mice. Green Processing and Synthesis. 2023;12(1):20230010. doi:10.1515/gps-2023-0010
   Web of Science ®Google Scholar
• Çetin FK, Ateş SC. In vitro investigation of Rutin-loaded PLGA nanoparticles on leishmania infantum promastigotes. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi. 2022;26(3):427–434. doi:10.19113/sdufenbed.1074029
   Google Scholar
• Surendran V, Palei NN. Formulation and characterization of rutin loaded chitosan-alginate nanoparticles: antidiabetic and cytotoxicity studies. Current Drug Delivery. 2022;19(3):379–394. doi:10.2174/1567201818666211005090656
   PubMed Web of Science ®Google Scholar
• Qi L, Xu Z, Jiang X, Hu C, Zou X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr. Res. 2004;339(16):2693–2700. doi:10.1016/j.carres.2004.09.007
   PubMed Web of Science ®Google Scholar
• Lu E, Franzblau S, Onyuksel H, Popescu C. Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion. J Microencapsul. 2009;26(4):346–354. doi:10.1080/02652040802365182
   PubMed Web of Science ®Google Scholar
• Siva D, Abinaya S, Rajesh D, et al. Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid. Nanomaterials. 2022;12(3):502. doi:10.3390/nano12030502
   Web of Science ®Google Scholar
• Al-Kassas R, Wen J, Cheng AE-M, Kim AM-J, Liu SSM, Yu J. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Carbohydr Polym. 2016;153:176–186. doi:10.1016/j.carbpol.2016.06.096
   PubMed Web of Science ®Google Scholar
• Kouchak M, Azarpanah A. Preparation and in vitro evaluation of chitosan nanoparticles containing diclofenac using the ion-gelation method. Jundishapur J Nat Pharm Prod. 2015;10(2):e23082. doi:10.17795/jjnpp-23082
   Google Scholar
• Hafizi T, Shahriari MH, Abdouss M, Kahdestani SA. Synthesis and characterization of vancomycin-loaded chitosan nanoparticles for drug delivery. Polym Bull. 2023;80(5):5607–5621. doi:10.1007/s00289-022-04237-8
   Web of Science ®Google Scholar
• Kiaie N, Aghdam RM, Tafti SH, Emami SH. Statistical optimization of chitosan nanoparticles as protein vehicles, using response surface methodology. J Appl Biomat Funct Mat. 2016;14(4):413–422. doi:10.5301/jabfm.5000278
   Web of Science ®Google Scholar
• Simpson E, Sarwar H, Jack I, Lowry D. Evaluation of the potential of chitosan nanoparticles as a delivery vehicle for gentamicin for the treatment of osteomyelitis. Antibiotics. 2024;13(3):208. doi:10.3390/antibiotics13030208
   Google Scholar
• Bahreini E, Aghaiypour K, Abbasalipourkabir R, Mokarram AR, Goodarzi MT, Saidijam M. Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study. Nanoscale Res Lett. 2014;9(1):340. doi:10.1186/1556-276X-9-340
   PubMedGoogle Scholar
• Calvo P, Remunan‐Lopez C, Vila‐Jato JL, Alonso M. Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997;63(1):125–132. doi:10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Web of Science ®Google Scholar
• Sreekumar S, Goycoolea FM, Moerschbacher BM, Rivera-Rodriguez GR. Parameters influencing the size of chitosan-TPP nano- and microparticles. Sci Rep. 2018;8(1):4695. doi:10.1038/s41598-018-23064-4
   PubMedGoogle Scholar
• Ways TMM, Filippov SK, Maji S, et al. Mucus-penetrating nanoparticles based on chitosan grafted with various non-ionic polymers: synthesis, structural characterisation and diffusion studies. J Colloid Interface Sci. 2022;626:251–264. doi:10.1016/j.jcis.2022.06.126
   PubMed Web of Science ®Google Scholar
• Di Martino A, Kucharczyk P, Capakova Z, Humpolicek P, Sedlarik V. Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles. J Nanopart Res. 2017;19(2):71. doi:10.1007/s11051-017-3756-3
   PubMed Web of Science ®Google Scholar
• Bozkir A, Saka OM. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Delivery. 2004;11(2):107–112. doi:10.1080/10717540490280705
   PubMed Web of Science ®Google Scholar
• Gregoriou Y, Gregoriou G, Yilmaz V, et al. Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells. Nanotheranostics. 2021;5(1):113–124. doi:10.7150/ntno.51955
   PubMedGoogle Scholar
• Wadher K, Trivedi S, Rarokar N, Umekar M. Development and assessment of rutin loaded transfersomes to improve ex vivo membrane permeability and in vitro efficacy. Hybrid Advances. 2024;5:100144. doi:10.1016/j.hybadv.2024.100144
   Google Scholar
• Alam MS, Sultana N, Rashid MA, et al. Quality by design-optimized glycerosome-enabled nanosunscreen gel of rutin hydrate. Gels. 2023;9(9):752. doi:10.3390/gels9090752
   PubMed Web of Science ®Google Scholar
• Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12(9):855. doi:10.3390/pharmaceutics12090855
   PubMed Web of Science ®Google Scholar
• Ramachandran R, Shanmughavel P. Preparation and characterization of biopolymeric nanoparticles used in drug delivery. Indian J Bioch BIoph. 2010;47:56–59.
   PubMed Web of Science ®Google Scholar
• Khadke S, Roces CB, Donaghey R, Giacobbo V, Su Y, Perrie Y. Scalable solvent-free production of liposomes. J Pharm Pharmacol. 2020;72(10):1328–1340. doi:10.1111/jphp.13329
   PubMed Web of Science ®Google Scholar
• Teng Z, Yu M, Ding Y, et al. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability. Int j Nanomed. 2019;14:119–133. doi:10.2147/IJN.S186899
   PubMed Web of Science ®Google Scholar
• Sultan MH, Moni SS, Madkhali OA, et al. Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer. Sci Rep. 2022;12(1):468. doi:10.1038/s41598-021-04427-w
   PubMed Web of Science ®Google Scholar
• Singh A, Kar AK, Singh D, et al. pH-responsive eco-friendly chitosan modified cenosphere/alginate composite hydrogel beads as carrier for controlled release of Imidacloprid towards sustainable pest control. Chem Eng J. 2022;427:131215. doi:10.1016/j.cej.2021.131215
   Web of Science ®Google Scholar
• Anitha A, Maya S, Deepa N, et al. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr Polym. 2011;83(2):452–461. doi:10.1016/j.carbpol.2010.08.008
   Web of Science ®Google Scholar
• Florento L, Matias R, Tuaño E, Santiago K, Dela Cruz F, Tuazon A. Comparison of cytotoxic activity of anticancer drugs against various human tumor cell lines using in vitro cell-based approach. Int j Biomed Sci. 2012;8(1):76. doi:10.59566/IJBS.2012.8076
   PubMedGoogle Scholar
• Biswas R, Mondal A, Chatterjee S, Ahn J. Evaluation of synergistic effects of sulforaphene with photodynamic therapy in human cervical cancer cell line. Lasers Med Sci. 2016;31(8):1675–1682. doi:10.1007/s10103-016-2037-1
   PubMed Web of Science ®Google Scholar
• Jakic B, Buszko M, Cappellano G, Wick G. Elevated sodium leads to the increased expression of HSP60 and induces apoptosis in HUVECs. PLoS One. 2017;12(6):e0179383. doi:10.1371/journal.pone.0179383
   PubMed Web of Science ®Google Scholar
• Ling L, Tan K, Lin H, Chiu G. The role of reactive oxygen species and autophagy in safingol-induced cell death. Cell Death Dis. 2011;2(3):e129–e129. doi:10.1038/cddis.2011.12
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Hou Z, Zhan C, Jiang Q, et al. Both FA-and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution. Nanoscale Res Lett. 2011;6:1–11. doi:10.1186/1556-276X-6-563
   Web of Science ®Google Scholar
• Seisel Q, Pelletier F, Deshayes S, Boisguerin P. How to evaluate the cellular uptake of CPPs with fluorescence techniques: dissecting methodological pitfalls associated to tryptophan-rich peptides. Bioch et Bioph Acta. 2019;1861(9):1533–1545. doi:10.1016/j.bbamem.2019.06.011
   Web of Science ®Google Scholar
• Shahjahan A, Sekar S, Kasinathan K, ArulJothi KN. The cytotoxic and anti-tumor potential of methanolic extracts of Indian marine isolates in HCT116 colorectal cancer cells. Anti Can Agent Med Chem. 2023;23(17):1974–1981.
   PubMed Web of Science ®Google Scholar
• Cocean G, Cocean A, Postolachi C, Garofalide S, Bulai G. High-power laser deposition of chitosan polymers: medical and environmental applications. Polymers. 2022;14(8):1537. doi:10.3390/polym14081537
   PubMed Web of Science ®Google Scholar
• El-Naggar NE-A, Shiha AM, Mahrous H, Mohammed ABA. Green synthesis of chitosan nanoparticles, optimization, characterization and antibacterial efficacy against multi drug resistant biofilm-forming Acinetobacter baumannii. Sci Rep. 2022;12(1):19869. doi:10.1038/s41598-022-24303-5
   PubMed Web of Science ®Google Scholar
• Yahya R, Al-Rajhi AMH, Alzaid SZ, et al. Molecular docking and efficacy of aloe vera gel based on chitosan nanoparticles against helicobacter pylori and its antioxidant and anti-inflammatory activities. Polymers. 2022;14(15):2994. doi:10.3390/polym14152994
   PubMed Web of Science ®Google Scholar
• Duraisamy N, Dhayalan S, Shaik MR, Shaik AH, Shaik JP, Shaik B. Green synthesis of chitosan nanoparticles using of martynia annua l. ethanol leaf extract and their antibacterial activity. Crystals. 2022;12(11):1550. doi:10.3390/cryst12111550
   Web of Science ®Google Scholar
• Abualhasan MN, Mansour J, Jaradat N, Zaid AN, Khadra I. Formulation and development of a validated UV-spectrophotometric analytical method of rutin tablet. Int Scholarly Res Notices. 2017;2017:1–7. doi:10.1155/2017/2624947
   Google Scholar
• Ganesan S, Alagarasan JK, Sonaimuthu M, et al. Preparation and characterization of salsalate-loaded chitosan nanoparticles: in vitro release and antibacterial and antibiofilm activity. Mar Drugs. 2022;20(12):733. doi:10.3390/md20120733
   PubMed Web of Science ®Google Scholar
• Chen D, Liu Y, Liu P, Zhou Y, Jiang L. Orally delivered rutin in lipid-based nano-formulation exerts strong antithrombotic effects by protein disulfide isomerase inhibition. Drug Delivery. 2022;29(1):1824–1835. doi:10.1080/10717544.2022.2083726
   PubMed Web of Science ®Google Scholar
• Kızılbey K. Optimization of rutin-loaded PLGA nanoparticles synthesized by single-emulsion solvent evaporation method. Acs Omega. 2019;4(1):555–562. doi:10.1021/acsomega.8b02767
   Web of Science ®Google Scholar
• Ciro Y, Rojas J, Di Virgilio AL, Alhajj MJ, Carabali GA, Salamanca CH. Production, physicochemical characterization, and anticancer activity of methotrexate-loaded phytic acid-chitosan nanoparticles on HT-29 human colon adenocarcinoma cells. Carbohydr Polym. 2020;243:116436. doi:10.1016/j.carbpol.2020.116436
   PubMed Web of Science ®Google Scholar
• Choudhary RC, Kumari S, Kumaraswamy R, et al. Characterization methods for chitosan-based nanomaterials. Plant Nanobionics. 2019;1:103–116.
   Google Scholar
• Lustriane C, Dwivany FM, Suendo V, Reza M. Effect of chitosan and chitosan-nanoparticles on post harvest quality of banana fruits. J Plant Biotechnol. 2018;45(1):36–44. doi:10.5010/JPB.2018.45.1.036
   Google Scholar
• Thai H, Thuy Nguyen C, Thi Thach L, et al. Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo. Sci Rep. 2020;10(1):1–15. doi:10.1038/s41598-020-57666-8
   PubMed Web of Science ®Google Scholar
• Goodarzi A, Khanmohammadi M, Ebrahimi-Barough S, et al. Alginate-based hydrogel containing taurine-loaded chitosan nanoparticles in biomedical application. Arch Neurosci. 2019;6(2):1.
   Web of Science ®Google Scholar
• Kain D, Kumar S. Synthesis and characterization of chitosan nanoparticles of Achillea millefolium L. and their activities. F1000Research. 2020;9:1297. doi:10.12688/f1000research.26446.1
   Google Scholar
• Mahmood MA, Madni A. Ionically cross-linked chitosan nanoparticles for sustained delivery of docetaxel: fabrication. Post-Formul Acute Oral Toxicity Eval. 2019;14:10035–10046.
   Google Scholar
• El-Houssiny A, Ward A, Mostafa D, et al. Drug–polymer interaction between glucosamine sulfate and alginate nanoparticles: FTIR, DSC and dielectric spectroscopy studies. Adv Nat Sci. 2016;7(2):025014.
   Google Scholar
• Ahmad N, Khan MR, Palanisamy S, Mohandoss S. Anticancer drug-loaded chitosan nanoparticles for in vitro release, promoting antibacterial and anticancer activities. Polymers. 2023;15(19):3925. doi:10.3390/polym15193925
   PubMed Web of Science ®Google Scholar
• IAd L, Khalil NM, Mainardes RM. A stability-indicating HPLC-PDA method for the determination of ferulic acid in chitosan-coated poly (lactide-co-glycolide) nanoparticles. Braz J Pharm Sci. 2017;2017:53.
   Google Scholar
• Pramod K, Ilyas UK, Kamal YT, Ahmad S, Ansari SH, Ali J. Development and validation of RP-HPLC-PDA method for the quantification of eugenol in developed nanoemulsion gel and nanoparticles. J Anal Sci Technol. 2013;4(1):16. doi:10.1186/2093-3371-4-16
   Google Scholar
• Güven UM, Berkman MS, Yazan Y. Development and validation of UPLC method for the determination of olopatadine hydrochloride in polymeric nanoparticles. Acta Pharm Sci. 2019;57:7–18.
   Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57. doi:10.3390/pharmaceutics10020057
   PubMed Web of Science ®Google Scholar
• Li C, Chen L, McClements DJ, et al. Preparation and characterization of rutin–loaded zein–carboxymethyl starch nanoparticles. Foods. 2022;11(18):2827. doi:10.3390/foods11182827
   PubMed Web of Science ®Google Scholar
• Saha S, Mishra A. A facile preparation of rutin nanoparticles and its effects on controlled growth and morphology of calcium oxalate crystals. Journal of Crystal Growth. 2020;540:125635. doi:10.1016/j.jcrysgro.2020.125635
   Web of Science ®Google Scholar
• AbdElrazek DA, Hassan NH, Ibrahim MA, Hassanen EI, Farroh KY, Abass HI. Ameliorative effects of rutin and rutin-loaded chitosan nanoparticles on testicular oxidative stress and histological damage induced by cyclophosphamide in male rats. Food and Chemical Toxicology. 2024;184:114436. doi:10.1016/j.fct.2024.114436
   PubMed Web of Science ®Google Scholar
• Sri KV, Santhoshini G, Sankar DR, Niharika K. Formulation and evaluation of rutin loaded nanosponges. Asian J Res Pharmac Sci. 2018;8(1):21–24. doi:10.5958/2231-5659.2018.00005.X
   Google Scholar
• Ardani H, Imawan C, Handayani W, Djuhana D, Harmoko A, Fauzia V Enhancement of the stability of silver nanoparticles synthesized using aqueous extract of Diospyros discolor Willd. leaves using polyvinyl alcohol. Paper presented at: IOP Conference Series: Materials Science and Engineering; 2017.
   Google Scholar
• Maguire CM, Rösslein M, Wick P, Prina-Mello A. Characterisation of particles in solution–a perspective on light scattering and comparative technologies. Sci Technol Adv Mater. 2018;19(1):732–745. doi:10.1080/14686996.2018.1517587
   PubMed Web of Science ®Google Scholar
• Erdogan O, Abbak M, Demirbolat GM, et al. Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: the characterization, anticancer potential with photodynamic therapy in MCF7 cells. PLoS One. 2019;14(6):e0216496. doi:10.1371/journal.pone.0216496
   PubMed Web of Science ®Google Scholar
• Wen X, Wang Q, Dai T, et al. Identification of possible reductants in the aqueous leaf extract of mangrove plant Rhizophora apiculata for the fabrication and cytotoxicity of silver nanoparticles against human osteosarcoma MG-63 cells. Mater Sci Eng C. 2020;116:111252. doi:10.1016/j.msec.2020.111252
   PubMed Web of Science ®Google Scholar
• Sangwan S, Seth R. Nanotechnology: a boon in cancer therapy. Internat J Nanomat. 2021;7(1):001–006.
   Google Scholar
• Lo Presti E, Pizzolato G, Corsale AM, et al. γδ T Cells and Tumor Microenvironment: from Immunosurveillance to Tumor Evasion. Front Immunol. 2018;9:1395–1395. doi:10.3389/fimmu.2018.01395
   PubMed Web of Science ®Google Scholar
• Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine (Lond). 2013;8(9):1509–1528. doi:10.2217/nnm.13.118
   PubMed Web of Science ®Google Scholar
• Jose Chirayil C, Abraham J, Kumar Mishra R, George SC, Thomas S. Chapter 1 - Instrumental Techniques for the Characterization of Nanoparticles. In: Thomas S, Thomas R, Zachariah AK, Mishra RK, editors. Thermal and Rheological Measurement Techniques for Nanomaterials Characterization. Elsevier; 2017:1–36.
   Google Scholar
• Clogston JD, Patri AK. Zeta potential measurement. Meth Mol Bio. 2011;697:63–70.
   PubMedGoogle Scholar
• Lu Y, Qi J, Wu W. Chapter 20 - Lipid nanoparticles: in vitro and in vivo approaches in drug delivery and targeting. In: Grumezescu AM, editor. Drug Targeting and Stimuli Sensitive Drug Delivery Systems. William Andrew Publishing; 2018:749–783.
   Google Scholar
• Aibani N, Rai R, Patel P. Chitosan nanoparticles at the biological interface: implications for drug delivery. Antioxidants. 2021;13(10):1.
   Google Scholar
• Piras AM, Maisetta G, Sandreschi S, et al. Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis. Front Microbiol. 2015;6:372. doi:10.3389/fmicb.2015.00372
   PubMed Web of Science ®Google Scholar
• Soltanzadeh M, Peighambardoust SH, Ghanbarzadeh B, Mohammadi M, Lorenzo JM. Chitosan nanoparticles as a promising nanomaterial for encapsulation of pomegranate (Punica granatum L.) peel extract as a natural source of antioxidants. Nanomaterials. 2021;11(6):1439. doi:10.3390/nano11061439
   Web of Science ®Google Scholar
• Vogel R, Pal AK, Jambhrunkar S, et al. High-resolution single particle zeta potential characterisation of biological nanoparticles using tunable resistive pulse sensing. Sci Rep. 2017;7(1):17479. doi:10.1038/s41598-017-14981-x
   PubMedGoogle Scholar
• Zhang L, Hu Y. Alphastatin-loaded chitosan nanoparticle preparation and its antiangiogenic effect on lung carcinoma. Int J Polym Sci. 2019;2019:1–9. doi:10.1155/2019/2751384
   Web of Science ®Google Scholar
• Chigumira W, Maposa P, Gadaga LL, Dube A, Tagwireyi D, Maponga CC. Preparation and evaluation of pralidoxime-loaded PLGA nanoparticles as potential carriers of the drug across the blood brain barrier. J Nanomater. 2015;2015:8–8. doi:10.1155/2015/692672
   Web of Science ®Google Scholar
• Liu X, Shan K, Shao X, et al. Nanotoxic effects of silver nanoparticles on normal HEK-293 cells in comparison to cancerous hela cell line. Int j Nanomed. 2021;16:753. doi:10.2147/IJN.S289008
   PubMed Web of Science ®Google Scholar
• Kaasalainen M, Aseyev V, von Haartman E, et al. Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering. Nanoscale Res Lett. 2017;12(1):74. doi:10.1186/s11671-017-1853-y
   PubMed Web of Science ®Google Scholar
• Yang G, Liu Y, Wang H, et al. Bioinspired core–shell nanoparticles for hydrophobic drug delivery. Angew. Chem. Int. Ed. 2019;58(40):14357–14364. doi:10.1002/anie.201908357
   PubMed Web of Science ®Google Scholar
• De Gaetano F, Cristiano MC, Venuti V, et al. Rutin-loaded solid lipid nanoparticles: characterization and in vitro evaluation. Molecules. 2021;26(4):1039. doi:10.3390/molecules26041039
   PubMed Web of Science ®Google Scholar
• Agrahari V, Youan -B-BC. Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine. AAPS Pharm Sci Tech. 2012;13:202–210. doi:10.1208/s12249-011-9735-6
   PubMed Web of Science ®Google Scholar
• Vigata M, Meinert C, Hutmacher DW, Bock N. Hydrogels as drug delivery systems: a review of current characterization and evaluation techniques. Pharmaceutics. 2020;12(12):1188. doi:10.3390/pharmaceutics12121188
   PubMed Web of Science ®Google Scholar
• Herrera M, Cantos J, Muñoz K, Durán J, Vinueza J, Dos Santos FK. Validation of analytical method by UV spectrophotometric quantification of gemfibrozil incorporated in the microemulsions. infoANALÍTICA. 2021;9(1):137–150. doi:10.26807/ia.v9i1.195
   Google Scholar
• Libánská A, Špringer T, Peštová L, et al. Using surface plasmon resonance, capillary electrophoresis and diffusion-ordered NMR spectroscopy to study drug release kinetics. Commun. Chem. 2023;6(1):180. doi:10.1038/s42004-023-00992-5
   PubMed Web of Science ®Google Scholar
• Dhole SM, Amnerkar ND, Khedekar PB. Comparison of UV spectrophotometry and high performance liquid chromatography methods for the determination of repaglinide in tablets. Pharm Methods. 2012;3(2):68–72. doi:10.4103/2229-4708.103875
   PubMedGoogle Scholar
• Wang Q, Wang G, Xie S, Zhao X, Zhang Y. Comparison of high‑performance liquid chromatography and ultraviolet‑visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano‑hydroxyapatite composite scaffolds. Exp Ther Med. 2019;17(4):2694–2702. doi:10.3892/etm.2019.7238
   PubMed Web of Science ®Google Scholar
• Dahiya P, Zafar A, Ahmad FJ, Khalid M, Ali A. Development of Forskolin and rutin-loaded polymeric nanoparticles for enhancement of topical ocular delivery: optimization, in-vitro, ex-vivo, and toxicity evaluation. J Drug Delivery Sci Technol. 2023;82:104292. doi:10.1016/j.jddst.2023.104292
   Web of Science ®Google Scholar
• Yoshida T, Lai TC, Kwon GS, Sako K. pH- and ion-sensitive polymers for drug delivery. Expert Opin Drug Delivery. 2013;10(11):1497–1513. doi:10.1517/17425247.2013.821978
   PubMed Web of Science ®Google Scholar
• Lee Y, Thompson DH. Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9(5). doi:10.1002/wnan.1450
   Web of Science ®Google Scholar
• AlSawaftah NM, Awad NS, Pitt WG, Husseini GA. pH-responsive nanocarriers in cancer therapy. Polymers. 2022;14(5):936. doi:10.3390/polym14050936
   PubMed Web of Science ®Google Scholar
• Yue H, Gou L, Tang Z, Liu Y, Liu S, Tang H. Construction of pH-responsive nanocarriers in combination with ferroptosis and chemotherapy for treatment of hepatocellular carcinoma. Cancer Nanotechnol. 2022;13(1):4. doi:10.1186/s12645-022-00111-4
   Web of Science ®Google Scholar
• Dhawa T, Hazra A, Barma A, Pal K, Karmakar P, Roy P. 4-Methyl-2, 6-diformylphenol based biocompatible chemosensors for pH: discrimination between normal cells and cancer cells. RSC Adv. 2020;10(26):15501–15513. doi:10.1039/D0RA00754D
   PubMed Web of Science ®Google Scholar
• Sonju JJ, Dahal A, Singh SS, et al. A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer. Int J Pharm. 2022;612:121364. doi:10.1016/j.ijpharm.2021.121364
   PubMedGoogle Scholar
• Saadat M, Mostafaei F, Mahdinloo S, et al. Drug delivery of pH-Sensitive nanoparticles into the liver cancer cells. J Drug Delivery Sci Technol. 2021;63:102557. doi:10.1016/j.jddst.2021.102557
   Web of Science ®Google Scholar
• Ghosh R, Mondal S, Mukherjee D, et al. Oral drug delivery using a polymeric nanocarrier: chitosan nanoparticles in the delivery of rifampicin. Mater Adv. 2022;3(11):4622–4628. doi:10.1039/D2MA00295G
   Google Scholar
• More KN, Mun S-K, Kang J, Kim -J-J, Yee S-T, Chang D-J. Molecular design of fluorescent pH sensors based on reduced rhodol by structure-pKa relationship for imaging of lysosome. Dyes Pigm. 2021;184:108785. doi:10.1016/j.dyepig.2020.108785
   Web of Science ®Google Scholar
• Wang Q, Zhou L, Qiu L, Lu D, Wu Y, Zhang X-B. An efficient ratiometric fluorescent probe for tracking dynamic changes in lysosomal pH. Analyst. 2015;140(16):5563–5569. doi:10.1039/C5AN00683J
   PubMed Web of Science ®Google Scholar
• Zheng Q, Cheng W, Zhang X, Shao R, Li Z. A pH-induced reversible assembly system with resveratrol-controllable loading and release for enhanced tumor-targeting chemotherapy. Nanoscale Res Lett. 2019;14(1):305. doi:10.1186/s11671-019-3139-z
   PubMed Web of Science ®Google Scholar
• Gaohua L, Miao X, Dou L. Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity. Expert Opin Drug Metab Toxicol. 2021;17(9):1103–1124. doi:10.1080/17425255.2021.1951223
   PubMed Web of Science ®Google Scholar
• Nasr M, Kira AY, Saber S, Essa EA, El-Gizawy SA. Telmisartan-Loaded lactosylated chitosan nanoparticles as a liver specific delivery system: synthesis, optimization and targeting efficiency. AAPS Pharm Sci Tech. 2023;24(6):144. doi:10.1208/s12249-023-02605-9
   PubMed Web of Science ®Google Scholar
• Li L, Zhang X, Pi C, et al. Review of Curcumin Physicochemical Targeting Delivery System. Int J Nanomed. 2020;15:9799–9821. doi:10.2147/IJN.S276201
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang Z, Peng Y, Ding J, Zhou W. A Smart pH-sensitive delivery system for enhanced anticancer efficacy via paclitaxel endosomal escape. Front Pharmacol. 2019;10:10. doi:10.3389/fphar.2019.00010
   PubMed Web of Science ®Google Scholar
• Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Drug release study of the chitosan-based nanoparticles. Heliyon. 2022;8(1):e08674. doi:10.1016/j.heliyon.2021.e08674
   PubMed Web of Science ®Google Scholar
• Medina-Moreno A, El-Hammadi MM, Arias JL. pH-dependent, extended release and enhanced in vitro efficiency against colon cancer of Tegafur formulated using chitosan-coated poly(ε-caprolactone) nanoparticles. J Drug Delivery Sci Technol. 2023;86:104594. doi:10.1016/j.jddst.2023.104594
   Web of Science ®Google Scholar
• Tian X, Shi A, Yin H, et al. Nanomaterials respond to lysosomal function for tumor treatment. Cells. 2022;11(21):3348. doi:10.3390/cells11213348
   PubMed Web of Science ®Google Scholar
• Augustine R, Hasan A, Primavera R, Wilson RJ, Thakor AS, Kevadiya BD. Cellular uptake and retention of nanoparticles: insights on particle properties and interaction with cellular components. Mater Today Commun. 2020;25:101692.
   Web of Science ®Google Scholar
• Dharmayanti C, Gillam TA, Klingler-Hoffmann M, Albrecht H, Blencowe A. Strategies for the development of pH-responsive synthetic polypeptides and polymer-peptide hybrids: recent advancements. Polymers. 2021;13(4):624. doi:10.3390/polym13040624
   PubMed Web of Science ®Google Scholar
• Guo K, Liu Y, Ding M, Sun Q, Shubhra QTH. Enhanced drug release from a pH-responsive nanocarrier can augment colon cancer treatment by blocking PD-L1 checkpoint and consuming tumor glucose. Mater Des. 2022;219:110824. doi:10.1016/j.matdes.2022.110824
   Web of Science ®Google Scholar
• Chu S, Shi X, Tian Y, Gao F. pH-responsive polymer nanomaterials for tumor therapy. Front Oncol. 2022;12:855019. doi:10.3389/fonc.2022.855019
   PubMed Web of Science ®Google Scholar
• Nallamuthu I, Devi A, Khanum F. Chlorogenic acid loaded chitosan nanoparticles with sustained release property, retained antioxidant activity and enhanced bioavailability. Asian J Pharm Sci. 2015;10(3):203–211. doi:10.1016/j.ajps.2014.09.005
   Web of Science ®Google Scholar
• Shahid N, Erum A, Zaman M, et al. Synthesis and evaluation of chitosan based controlled release nanoparticles for the delivery of ticagrelor. Des. Monomers Polym. 2022;25(1):55–63. doi:10.1080/15685551.2022.2054117
   PubMed Web of Science ®Google Scholar
• Imtiyaz Z, He J, Leng Q, Agrawal AK, Mixson AJ. pH-sensitive targeting of tumors with chemotherapy-laden nanoparticles: progress and challenges. Pharmaceutics. 2022;14(11):2427. doi:10.3390/pharmaceutics14112427
   PubMed Web of Science ®Google Scholar
• Argitekin E, Ersoz-Gulseven E, Cakan-Akdogan G, Akdogan Y. Dopamine-conjugated bovine serum albumin nanoparticles containing pH-responsive catechol-V (III) coordination for in vitro and in vivo drug delivery. Biomacromolecules. 2023;24(8):3603–3618. doi:10.1021/acs.biomac.3c00363
   PubMed Web of Science ®Google Scholar
• Virmani T, Kumar G, Sharma A, et al. Amelioration of cancer employing chitosan, its derivatives, and chitosan-based nanoparticles: recent updates. Polymers. 2023;15(13):2928. doi:10.3390/polym15132928
   PubMed Web of Science ®Google Scholar
• Meng F, Cheng R, Deng C, Zhong Z. Intracellular drug release nanosystems. Mater Today. 2012;15(10):436–442. doi:10.1016/S1369-7021(12)70195-5
   Web of Science ®Google Scholar
• Niu N, Wang L. In vitro human cell line models to predict clinical response to anticancer drugs. Pharmacogenomics. 2015;16(3):273–285. doi:10.2217/pgs.14.170
   PubMed Web of Science ®Google Scholar
• Pan E, Bogumil D, Cortessis V, Yu S, Nieva J. A systematic review of the efficacy of preclinical models of lung cancer drugs. Front Oncol. 2020;10:591. doi:10.3389/fonc.2020.00591
   PubMed Web of Science ®Google Scholar
• Kumar N, Afjei R, Massoud TF, Paulmurugan R. Comparison of cell-based assays to quantify treatment effects of anticancer drugs identifies a new application for Bodipy-L-cystine to measure apoptosis. Sci Rep. 2018;8(1):16363. doi:10.1038/s41598-018-34696-x
   PubMedGoogle Scholar
• Wadhawan A, Singh J, Sharma H, et al. Anticancer biosurfactant-loaded PLA–PEG nanoparticles induce apoptosis in human MDA-MB-231 breast cancer cells. ACS omega. 2022;7(6):5231–5241. doi:10.1021/acsomega.1c06338
   PubMed Web of Science ®Google Scholar
• Yao Y, Zhou Y, Liu L, et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci. 2020;7:193. doi:10.3389/fmolb.2020.00193
   PubMed Web of Science ®Google Scholar
• Gallego NE, Wray S, Preza E, Abramov AY. Higher mitochondrial membrane potential induces ROS production in the familiar form of frontotemporal dementia with MAPT mutations. Biophys. J. 2015;108(2):1.
   PubMed Web of Science ®Google Scholar
• Rovini A, Heslop K, Hunt EG, et al. Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells. FASEB J. 2021;35(1):e21148. doi:10.1096/fj.202001693R
   PubMed Web of Science ®Google Scholar
• Zorova LD, Popkov VA, Plotnikov EY, et al. Mitochondrial membrane potential. Anal Biochem. 2018;552:50–59. doi:10.1016/j.ab.2017.07.009
   PubMed Web of Science ®Google Scholar
• Backes S, Herrmann JM. Protein translocation into the intermembrane space and matrix of mitochondria: mechanisms and driving forces. Front Mol Biosci. 2017;4:83. doi:10.3389/fmolb.2017.00083
   PubMed Web of Science ®Google Scholar
• Kalvelytė AV, Imbrasaitė A, Krestnikova N, Stulpinas A. Chapter Four - Adult Stem Cells and Anticancer Therapy. In: Fishbein JC, Heilman JM, editors. Advances in Molecular Toxicology. Vol. 11. Elsevier; 2017:123–202.
   Google Scholar
• Wang Y, Xu E, Musich PR, Lin F. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther. 2019;25(7):816–824. doi:10.1111/cns.13116
   PubMed Web of Science ®Google Scholar
• van der Stel W, Yang H, le Dévédec SE, van de Water B, Beltman JB, Danen EHJ. High-content high-throughput imaging reveals distinct connections between mitochondrial morphology and functionality for OXPHOS complex I, III, and V inhibitors. Cell Biol Toxicol. 2022;2022:1.
   Google Scholar
• Norat P, Soldozy S, Sokolowski JD, et al. Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation. Npj Regenerat Med. 2020;5(1):22. doi:10.1038/s41536-020-00107-x
   PubMed Web of Science ®Google Scholar
• Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders — a step towards mitochondria based therapeutic strategies. Bioch et Bioph Acta. 2017;1863(5):1066–1077. doi:10.1016/j.bbadis.2016.11.010
   PubMed Web of Science ®Google Scholar
• Bagkos G, Koufopoulos K, Piperi C. A new model for mitochondrial membrane potential production and storage. Med Hypotheses. 2014;83(2):175–181. doi:10.1016/j.mehy.2014.05.001
   PubMed Web of Science ®Google Scholar
• Kim SY. Cancer energy metabolism: shutting power off cancer factory. Biomol Ther. 2018;26(1):39–44. doi:10.4062/biomolther.2017.184
   PubMed Web of Science ®Google Scholar
• Vultaggio-Poma V, Sarti AC, Di Virgilio F. Extracellular ATP: a Feasible Target for Cancer Therapy. Cells. 2020;9(11):2496. doi:10.3390/cells9112496
   PubMed Web of Science ®Google Scholar
• Yang Y, Bai J, Du W, Kong D. The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis. Front Pharmacol. 2023;14:1243613. doi:10.3389/fphar.2023.1243613
   PubMed Web of Science ®Google Scholar
• Lyamzaev KG, Tokarchuk AV, Panteleeva AA, Mulkidjanian AY, Skulachev VP, Chernyak BV. Induction of autophagy by depolarization of mitochondria. Autophagy. 2018;14(5):921–924. doi:10.1080/15548627.2018.1436937
   PubMed Web of Science ®Google Scholar
• Johnson TA, Jinnah H, Kamatani N. Shortage of cellular ATP as a cause of diseases and strategies to enhance ATP. Front Pharmacol. 2019;10:98. doi:10.3389/fphar.2019.00098
   PubMed Web of Science ®Google Scholar
• Mori K, Uchida T, Yoshie T, et al. A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS‐activated cancer cells. FEBS J. 2019;286(3):459–478. doi:10.1111/febs.14671
   PubMed Web of Science ®Google Scholar
• Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8(21):2003–2014. doi:10.3969/j.issn.1673-5374.2013.21.009
   PubMed Web of Science ®Google Scholar
• Manke A, Wang L, Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 2013;2013:942916. doi:10.1155/2013/942916
   PubMed Web of Science ®Google Scholar
• Fu PP, Xia Q, Hwang H-M, Ray PC, Yu H. Mechanisms of nanotoxicity: generation of reactive oxygen species. Journal of Food and Drug Analysis. 2014;22(1):64–75. doi:10.1016/j.jfda.2014.01.005
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 2019;9(11):735. doi:10.3390/biom9110735
   PubMed Web of Science ®Google Scholar
• Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Bioch et Bioph Acta. 2016;1863(12):2977–2992. doi:10.1016/j.bbamcr.2016.09.012
   PubMed Web of Science ®Google Scholar
• Perillo B, Di Donato M, Pezone A, et al. ROS in cancer therapy: the bright side of the moon. Exp. Mol. Med. 2020;52(2):192–203. doi:10.1038/s12276-020-0384-2
   PubMed Web of Science ®Google Scholar
• Hasan A, Rizvi SF, Parveen S, Pathak N, Nazir A, Mir SS. Crosstalk between ROS and autophagy in tumorigenesis: understanding the multifaceted paradox. Front Oncol. 2022;2022:12.
   Google Scholar
• Kma L, Baruah TJ. The interplay of ROS and the PI3K/Akt pathway in autophagy regulation. Feb. 2022;69(1):248–264.
   Google Scholar
• Hoy MA. Chapter 8 - DNA Amplification by the Polymerase Chain Reaction: molecular Biology Made Accessible. In: Hoy MA, editor. Insect Molecular Genetics. San Diego: Academic Press; 2013:307–372.
   Google Scholar
• Lobert S, Hiser L, Correia JJ. Chapter 4 - Expression Profiling of Tubulin Isotypes and Microtubule-Interacting Proteins Using Real-Time Polymerase Chain Reaction. In: Wilson L, Correia JJ, editors. Methods in Cell Biology. Vol 95: Academic Press; 2010:47–58.
   Google Scholar
• Ozturk M, Ozsoylemez OD, Dagistanli FK. The detection techniques for autophagy-associated cell death-related genes and proteins: gene expression assay and Immunohistochemistry. Meth Mol Bio. 2019;1854:119–130.
   PubMedGoogle Scholar
• Jiang Z, Liu J, Chen B, et al. Cytotoxic effects of a sesquiterpene β-elemene on THP-1 leukemia cells is mediated via crosstalk between beclin-1 mediated autophagy and caspase-dependent apoptosis. Process Biochem. 2019;87:174–178. doi:10.1016/j.procbio.2019.09.006
   Web of Science ®Google Scholar
• Amatori S, Persico G, Fanelli M. Real-time quantitative PCR array to study drug-induced changes of gene expression in tumor cell lines. J Cancer Metastasis Treat. 2017;3(5):90–99. doi:10.20517/2394-4722.2017.22
   Google Scholar
• Levine B, Kroemer G. SnapShot: macroautophagy. Cell. 2008;132(1):162.e161–162.e163. doi:10.1016/j.cell.2007.12.026
   Web of Science ®Google Scholar
• Dong L, He J, Luo L, Wang K. Targeting the interplay of autophagy and ros for cancer therapy: an updated overview on phytochemicals. Pharmaceuticals. 2023;16(1). doi:10.3390/ph16010092
   Web of Science ®Google Scholar
• Trelford CB, Di Guglielmo GM. Canonical and non-canonical TGFβ signaling activate autophagy in an ULK1-dependent manner. Front Cell Develop Biol. 2021;9:712124. doi:10.3389/fcell.2021.712124
   PubMed Web of Science ®Google Scholar
• Nam KH, Yi SA, Nam G, et al. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer. BMC Cancer. 2019;19(1):773. doi:10.1186/s12885-019-5997-2
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu L, Zhang S, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017;8(4):2687–2701. doi:10.1039/C6SC05368H
   PubMed Web of Science ®Google Scholar
• Li C, Xu H, Chen X, et al. Aqueous extract of clove inhibits tumor growth by inducing autophagy through AMPK/ULK pathway. Phytoth Res. 2019;33(7):1794–1804. doi:10.1002/ptr.6367
   PubMed Web of Science ®Google Scholar
• Ye X, Zhou XJ, Zhang H. Exploring the role of autophagy-related gene 5 (ATG5) yields important insights into autophagy in autoimmune/autoinflammatory diseases. Front Immunol. 2018;9:2334. doi:10.3389/fimmu.2018.02334
   PubMed Web of Science ®Google Scholar
• Kadowaki M, Karim MR. Cytosolic LC3 ratio as a quantitative index of macroautophagy. Methods Enzymol. 2009;452:199–213.
   PubMed Web of Science ®Google Scholar
• Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 2004;36(12):2503–2518. doi:10.1016/j.biocel.2004.05.009
   PubMed Web of Science ®Google Scholar
• Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19(21):5720–5728. doi:10.1093/emboj/19.21.5720
   PubMed Web of Science ®Google Scholar
• Dooley HC, Razi M, Polson HE, Girardin SE, Wilson MI, Tooze SA. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12–5-16L1. Molecular Cell. 2014;55(2):238–252. doi:10.1016/j.molcel.2014.05.021
   PubMed Web of Science ®Google Scholar
• Mackeh R, Perdiz D, Lorin S, Codogno P, Poüs C. Autophagy and microtubules–new story, old players. J Cell Sci. 2013;126(5):1071–1080. doi:10.1242/jcs.115626
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Eskelinen E-L, Deretic V. Autophagosomes, Phagosomes, Autolysosomes, Phagolysosomes, Autophagolysosomes… Wait, I’m Confused. Vol. 10. Taylor & Francis; 2014:549–551.
   Google Scholar
• Kudriaeva AA, Sokolov AV, Belogurov AAJ. Stochastics of degradation: the autophagic-lysosomal system of the cell. Acta naturae. 2020;12(1):18–32. doi:10.32607/actanaturae.10936
   PubMed Web of Science ®Google Scholar
• Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunol Res. 2014;2(9):823–830. doi:10.1158/2326-6066.CIR-14-0112
   PubMed Web of Science ®Google Scholar
• Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12(1):86. doi:10.1186/1476-4598-12-86
   PubMed Web of Science ®Google Scholar
• Cartwright T, Perkins NDL, Wilson C. NFKB1: a suppressor of inflammation, ageing and cancer. FEBS J. 2016;283(10):1812–1822. doi:10.1111/febs.13627
   PubMed Web of Science ®Google Scholar
• Concetti J, Wilson CL. NFKB1 and Cancer: friend or Foe? Cells. 2018;7(9):133. doi:10.3390/cells7090133
   PubMed Web of Science ®Google Scholar
• Zilfou JT, Lowe SW. Tumor suppressive functions of p53. Cold Spring Harbor Perspect. Biol. 2009;1(5):a001883–a001883. doi:10.1101/cshperspect.a001883
   PubMed Web of Science ®Google Scholar
• Jin S. Autophagy and tumor suppression. Autophagy. 2005;1(3):171–173. doi:10.4161/auto.1.3.2051
   PubMed Web of Science ®Google Scholar
• Lowe JM, Menendez D, Bushel PR, et al. p53 and NF-κB coregulate proinflammatory gene responses in human macrophages. Cancer Res. 2014;74(8):2182–2192. doi:10.1158/0008-5472.CAN-13-1070
   PubMed Web of Science ®Google Scholar
• Salminen A, Hyttinen JM, Kauppinen A, Kaarniranta K. Context-dependent regulation of autophagy by IKK-NF- κ B signaling: impact on the aging process. Int J Cell Biol. 2012;2012:1–15. doi:10.1155/2012/849541
   Google Scholar
• Mi W, Wang C, Luo G, et al. Targeting ERK induced cell death and p53/ROS-dependent protective autophagy in colorectal cancer. Cell Death Discovery. 2021;7(1):375. doi:10.1038/s41420-021-00677-9
   PubMed Web of Science ®Google Scholar
• Zhao X, Jiang K, Liang B, Huang X. Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway. Oncol Rep. 2016;35(2):669–675. doi:10.3892/or.2015.4455
   PubMed Web of Science ®Google Scholar
• White E. Autophagy and p53. Cold Spring Harb Perspect Med. 2016;6(4):a026120. doi:10.1101/cshperspect.a026120
   PubMed Web of Science ®Google Scholar
• Rahman MA, Park MN, Rahman M, et al. p53 modulation of autophagy signaling in cancer therapies: perspectives mechanism and therapeutic targets. Front Cell Develop Biol. 2022;10:761080. doi:10.3389/fcell.2022.761080
   PubMed Web of Science ®Google Scholar
• Gugnoni M, Sancisi V, Manzotti G, Gandolfi G, Ciarrocchi A. Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer. Cell Death Dis. 2016;7(12):e2520–e2520. doi:10.1038/cddis.2016.415
   PubMedGoogle Scholar
• Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6):100773. doi:10.1016/j.tranon.2020.100773
   PubMed Web of Science ®Google Scholar
• Lu W, Kang Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev. Cell. 2019;49(3):361–374. doi:10.1016/j.devcel.2019.04.010
   PubMed Web of Science ®Google Scholar
• Kaszak I, Witkowska-Piłaszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P. Role of cadherins in cancer-a review. Int J Mol Sci. 2020;21(20):7624. doi:10.3390/ijms21207624
   PubMed Web of Science ®Google Scholar
• Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001;153(5):1049–1060. doi:10.1083/jcb.153.5.1049
   PubMed Web of Science ®Google Scholar
• T-Y N, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci. 2020;117(11):5931–5937. doi:10.1073/pnas.1918167117
   PubMed Web of Science ®Google Scholar
• Wang Y, Shi J, Chai K, Ying X, Zhou BP. The role of snail in EMT and tumorigenesis. Curr Cancer Drug Targets. 2013;13(9):963–972. doi:10.2174/15680096113136660102
   PubMed Web of Science ®Google Scholar
• Usman S, Waseem NH, Nguyen TKN, Mohsin S. Vimentin is at the heart of epithelial mesenchymal transition (EMT) Mediated metastasis. Cancers. 2021;13(19):4985. doi:10.3390/cancers13194985
   PubMed Web of Science ®Google Scholar
• Jonckheere S, Adams J, De Groote D, Campbell K, Berx G, Goossens S. Epithelial-mesenchymal transition (EMT) as a therapeutic target. Cells Tissues Organs. 2022;211(2):157–182. doi:10.1159/000512218
   PubMed Web of Science ®Google Scholar
• Hui San S, Ching Ngai S. E-cadherin re-expression: its potential in combating TRAIL resistance and reversing epithelial-to-mesenchymal transition. Gene. 2024;909:148293. doi:10.1016/j.gene.2024.148293
   PubMed Web of Science ®Google Scholar
• Takeda T, Tsubaki M, Matsuda T, et al. EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells. Oncol Rep. 2022;47(6):1–13. doi:10.3892/or.2022.8320
   PubMed Web of Science ®Google Scholar
• Mazumdar S, Chitkara D, Mittal A. Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers. Acta Pharmaceutica Sinica B. 2021;11(4):903–924. doi:10.1016/j.apsb.2021.02.019
   PubMed Web of Science ®Google Scholar
• Qiu C, Xia F, Zhang J, et al. Advanced strategies for overcoming endosomal/lysosomal barrier in nanodrug delivery. Research. 2023;6:0148. doi:10.34133/research.0148
   PubMedGoogle Scholar
• Aibani N, Rai R, Patel P, Cuddihy G, Wasan EK. Chitosan nanoparticles at the biological interface: implications for drug delivery. Pharmaceutics. 2021;13(10):1686. doi:10.3390/pharmaceutics13101686
   PubMed Web of Science ®Google Scholar
• Rathore B, Sunwoo K, Jangili P, et al. Nanomaterial designing strategies related to cell lysosome and their biomedical applications: a review. Biomaterials. 2019;211:25–47. doi:10.1016/j.biomaterials.2019.05.002
   PubMed Web of Science ®Google Scholar
• Yang JM, Wu LJ, Lin MT, et al. Construction and evaluation of chitosan-based nanoparticles for oral administration of exenatide in type 2 diabetic rats. Polymers. 2022;14(11). doi:10.3390/polym14112181
   Web of Science ®Google Scholar
• Jin H, Pi J, Yang F, et al. Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo. Sci Rep. 2016;6(1):30782. doi:10.1038/srep30782
   PubMedGoogle Scholar
• Campoccia D, Ravaioli S, Santi S, et al. Exploring the anticancer effects of standardized extracts of poplar-type propolis: in vitro cytotoxicity toward cancer and normal cell lines. Biomed. Pharmacother. 2021;141:111895. doi:10.1016/j.biopha.2021.111895
   PubMed Web of Science ®Google Scholar
• Hadjzadeh M-A-R, Ghanbari H, Keshavarzi Z, Tavakol-Afshari J. The effects of aqueous extract of Alpinia galangal on gastric cancer cells (AGS) and L929 cells in vitro. Iran J Cancer Prev. 2014;7(3):142–146.
   PubMedGoogle Scholar
• Chang M-C, J-Y W, Liao H-F, Chen Y-J, Kuo C-D. Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: a quantitative pilot study. Medicine. 2016;95(31):e4467–e4467. doi:10.1097/MD.0000000000004467
   PubMed Web of Science ®Google Scholar
• Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett. 2021;16(1):173. doi:10.1186/s11671-021-03628-6
   PubMed Web of Science ®Google Scholar
• Nalezinková M. In vitro hemocompatibility testing of medical devices. Thromb Res. 2020;195:146–150. doi:10.1016/j.thromres.2020.07.027
   PubMed Web of Science ®Google Scholar
• Weber M, Steinle H, Golombek S, et al. Blood-contacting biomaterials: in vitro evaluation of the hemocompatibility. Front Bioeng Biotechnol. 2018;6:99. doi:10.3389/fbioe.2018.00099
   PubMed Web of Science ®Google Scholar
• Kuchinka J, Willems C, Telyshev DV. Control of blood coagulation by hemocompatible material surfaces-a review. Bioengineering. 2021;8(12). doi:10.3390/bioengineering8120215
   PubMedGoogle Scholar
• Li X, Wang L, Fan Y, Feng Q, Cui F-Z. Biocompatibility and toxicity of nanoparticles and nanotubes. J Nanomater. 2012;2012:6–6.
   Web of Science ®Google Scholar
• Malehmir S, Esmaili MA, Mahabady MK, et al. A review: hemocompatibility of magnetic nanoparticles and their regenerative medicine, cancer therapy, drug delivery, and bioimaging applications. Front Chem. 2023;11:1249134. doi:10.3389/fchem.2023.1249134
   PubMed Web of Science ®Google Scholar